Tuttnauer Knowledge Center Bulb

Formaldehyde Sterilization: Low-Temperature Steam and Formaldehyde

Low-temperature steam and formaldehyde (LTSF) sterilization uses formaldehyde gas mixed with saturated steam at 60–80 °C to alkylate microbial DNA and proteins. It is used in some European countries for heat-sensitive medical devices but is not FDA-cleared in the United States, and its share of the global low-temperature sterilization market is shrinking as carcinogenicity and exposure regulations tighten and as alternatives — hydrogen peroxide plasma, ozone, and emerging methods — gain ground.

This article explains how LTSF works, the cycle structure, where it is still used, its safety profile, and how it compares to other low-temperature methods.

How LTSF Sterilization Works

Formaldehyde (HCHO) is a small, reactive aldehyde that kills microorganisms by alkylation — it transfers a methylol group to nucleophilic sites on proteins (amino, sulfhydryl, hydroxyl) and on nucleic acids (amino groups of bases). The cross-links it forms denature enzymes, structural proteins, and DNA, halting microbial replication.

Formaldehyde alone is not an efficient sterilant under normal conditions. Activity rises sharply with moisture, because the gas dissolves into the surface water film around microbial cells where reaction occurs. LTSF combines formaldehyde with saturated steam to provide the moisture required and to deliver heat that accelerates the reaction.

Important: Effective LTSF sterilization requires high formaldehyde concentration, temperature 60–80 °C, and 75–100 % relative humidity. Outside this envelope, the cycle does not reliably achieve SAL 10⁻⁶.

The LTSF Cycle

A typical LTSF cycle has four phases.

1. Initial Vacuum

The chamber is evacuated to remove air. Several pulses of vacuum and steam admission may be used to displace residual air and pre-heat the load.

2. Steam Admission and Load Heating

Saturated steam is admitted to bring the load to target temperature (60–80 °C) and to establish humidity (75–100 % RH). The vacuum pump runs to flush out remaining air and condensate.

3. Formaldehyde Pulses

Liquid formaldehyde (typically a 2 % aqueous solution, formalin) is metered through a heated evaporator. Formaldehyde gas, mixed with steam, is pulsed into the chamber. Multiple pulses ensure penetration to all surfaces of the load. The chamber holds at temperature, humidity, and formaldehyde concentration for the validated exposure time.

4. Removal and Aeration

Formaldehyde and any residual condensate are removed by repeated alternate evacuations and flushing with steam and air. Modern LTSF cycles end with the load reasonably free of residual formaldehyde, though residue verification is required for sensitive applications.

ParameterTypical value
Temperature60–80 °C
Relative humidity75–100 %
PressureSub-atmospheric (vacuum cycles)
Cycle time3–5 hours
SterilantFormaldehyde (~2 % formalin) + steam

What Is Sterilized with Formaldehyde

LTSF is used for heat-sensitive devices that cannot tolerate steam at 121 °C, and where local regulations and infrastructure favor formaldehyde over alternatives:

  • Rigid and flexible endoscopes (where IFU specifies LTSF compatibility)
  • Heat-sensitive instruments for ophthalmic and microsurgery
  • Cryo-instruments and similar devices with sealed mechanisms
  • Plastic syringes, coils, and tubing in some industrial applications

LTSF is not suitable for:

  • Materials sensitive to moisture or 80 °C heat
  • Liquids and powders
  • Materials that absorb formaldehyde and cannot be adequately rinsed (some adhesives, certain absorbent materials)

Advantages

  • Faster cycle than EtO (3–5 hours vs >14 hours plus days of aeration)
  • Lower per-cycle cost than EtO
  • Effective against bacterial spores as well as vegetative cells, viruses, and fungi
  • Faster aeration than EtO — most loads are usable shortly after cycle end
  • Smaller difference in resistance between spores and vegetative cells than EtO (consistent kill profile)

Limitations and Safety

  • Carcinogenic — formaldehyde is classified by the IARC as a Group 1 human carcinogen
  • Acutely toxic — eye and respiratory irritation begins at concentrations above 0.1 ppm
  • Pungent odor at sub-toxic concentrations
  • Allergenic — sensitization can develop with repeated exposure
  • Higher operating temperature than EtO (60–80 °C vs 25–55 °C) — some devices that tolerate EtO may not tolerate LTSF
  • Weaker penetration of long lumens than EtO
  • Residual formaldehyde can remain on sterilized devices if rinsing/aeration is inadequate
  • Regulatory scrutiny — increasingly restricted in the EU, banned or discouraged in several jurisdictions

Regulatory note: Formaldehyde and formaldehyde-releasing products are subject to tightening REACH and CLP restrictions in the EU. Several countries that historically used LTSF are migrating to alternatives.

LTSF vs EtO vs H₂O₂ Plasma

FactorLTSFEtOH₂O₂ Plasma
SterilantFormaldehyde + steamEthylene oxideH₂O₂ vapor + plasma
Temperature60–80 °C25–55 °C45–55 °C
Cycle time3–5 h>14 h + aeration35–75 min
Aeration requiredMinimal24–48+ hNone
Carcinogenicity (sterilant)Yes (Group 1)Yes (Group 1)No
Long lumen capabilityModerateExcellentLimited
FDA cleared (US healthcare)NoYesYes
EU acceptanceDecliningRestrictedYes
Material compatibilityModerateVery broadBroad except cellulose

For modern hospitals choosing a low-temperature method, hydrogen peroxide plasma is generally preferred over LTSF on safety, cycle-time, and regulatory-trajectory grounds. LTSF retains a role only where infrastructure is established and the local regulatory regime allows it.

Regulatory Standards

  • EN 14180 — Sterilizers for medical purposes: Low-temperature steam and formaldehyde sterilizers; requirements and testing.
  • ISO 25424 — Sterilization of health care products: Low temperature steam and formaldehyde. Requirements for development, validation, and routine control.
  • EU REACH and CLP regulations — formaldehyde classified Carc. 1B and Muta. 2, with restrictions on consumer and certain industrial uses.
  • OSHA 29 CFR 1910.1048 (US) — formaldehyde occupational exposure standard; PEL 0.75 ppm (8-h TWA), 2 ppm STEL (15-min).
  • No FDA 510(k) clearance for LTSF as a healthcare facility sterilization method in the United States.

LTSF use is concentrated in the United Kingdom, Germany, Sweden, Denmark, Norway, and a small number of other European countries. Several have begun phasing it out in favor of hydrogen peroxide alternatives.

FAQ

Is formaldehyde sterilization used in the United States?

No. LTSF is not FDA-cleared as a sterilization method for healthcare facilities in the US. US hospitals use steam, hydrogen peroxide plasma, EtO, or ozone instead.

Why is formaldehyde sterilization being phased out?

Formaldehyde is a Group 1 human carcinogen. Tightening EU REACH/CLP rules, occupational exposure regulations, and the availability of safer alternatives (hydrogen peroxide plasma, ozone) make LTSF less attractive on both safety and compliance grounds. Adoption is decreasing year over year in most markets.

Is formaldehyde sterilization the same as formalin disinfection?

No. Formalin (a 37 % aqueous solution of formaldehyde) is widely used as a tissue fixative and as a high-level disinfectant. LTSF is a sterilization process performed in a sealed chamber under controlled temperature, humidity, and gas concentration to achieve SAL 10⁻⁶ — not the same as soaking instruments in formalin.

How long does LTSF sterilization take?

A typical LTSF cycle is 3–5 hours, including vacuum, heating, sterilant pulses, exposure, and removal. This is significantly faster than EtO but slower than hydrogen peroxide plasma.

What devices are sterilized with LTSF?

Heat-sensitive medical devices — primarily endoscopes, ophthalmic and microsurgical instruments, and certain plastic medical components — in jurisdictions that have approved LTSF and where local infrastructure supports it.

Are formaldehyde residuals on devices a concern?

Yes. Residuals can cause patient irritation or allergic response. Modern LTSF cycles include extended evacuation/flush phases to remove formaldehyde, but residual verification is required for sensitive applications and is part of the validation under EN 14180 / ISO 25424.

Conclusion

Formaldehyde sterilization remains a valid low-temperature option in jurisdictions where it is approved and infrastructure is established, but its market share is shrinking. The combination of carcinogenicity, exposure regulation, and superior alternatives means LTSF is rarely the right answer for new installations. For modern healthcare facilities choosing a low-temperature method, hydrogen peroxide plasma and ozone are the dominant alternatives; for industrial-scale sterilization of packaged disposables, gamma irradiation and EtO remain the workhorses. Compare adjacent methods at the sterilization methods overview.

United Kingdom